Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Chang, Andrew Y ^a   Bhattacharya, Nupur ^a   Mu, Jian ^b   Setiadi, A Francesca ^a   Carcamo Cavazos, Valeria ^a   Lee, Gerald H ^a   Simons, Diana L ^a,e   Yadegarynia, Sina ^a   Hemati, Kaveh ^a   Kapelner, Adam ^c   Ming, Zheng ^a   Krag, David N ^d   Schwartz, Erich J ^a   Chen, Danny Z ^b   Lee, Peter P ^a,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Notre Dame   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Clustering; Dendritic cells; Immune cells; Lymph nodes; Spatial organization

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CELL FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TUMOR DRAINING LYMPH NODE; TUMOR IMMUNITY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL AGGREGATION; CELL COUNT; CELL DIFFERENTIATION; CLUSTER ANALYSIS; DENDRITIC CELLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MIDDLE AGED; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 84884796701     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-242     Document Type: Article

References (35)

1. Menard S, Tomasic G, Casalini P, Balsari A, Pilotti S, Cascinelli N, Salvadori B, Colnaghi MI, Rilke F. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res 1997, 3(5):817-819.
2. Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, et al. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res 2009, 11(2):R15. 10.1186/bcr2234, 2688939, 19272155.
3. Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, Mabuchi H, Nohara T, Gon G, Toyoda M, Tanigawa N. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 2003, 104(1):92-97. 10.1002/ijc.10915, 12532424.
4. Hoffmann TK, Muller-Berghaus J, Ferris RL, Johnson JT, Storkus WJ, Whiteside TL. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck. Clin Cancer Res 2002, 8(6):1787-1793.
5. Lissoni P, Malugani F, Bonfanti A, Bucovec R, Secondino S, Brivio F, Ferrari-Bravo A, Ferrante R, Vigore L, Rovelli F, et al. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. J Biol Regul Homeost Agents 2001, 15(2):140-144.
6. Lissoni P, Vigore L, Ferranti R, Bukovec R, Meregalli S, Mandala M, Barni S, Tancini G, Fumagalli L, Giani L. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. J Biol Regul Homeost Agents 1999, 13(4):216-219.
7. Yamakawa M, Yamada K, Orui H, Tsuge T, Ogata T, Dobashi M, Imai Y. Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas. Anal Cell Pathol 1995, 8(4):331-343.
8. Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain SN, Di Leo A, Piccart M, Verhest A, Larsimont D. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer 1999, 84(3):309-314. 10.1002/(SICI)1097-0215(19990621)84:3<309::AID-IJC19>3.0.CO;2-3, 10371352.
9. Ambe K, Mori M, Enjoji M. S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 1989, 63(3):496-503. 10.1002/1097-0142(19890201)63:3<496::AID-CNCR2820630318>3.0.CO;2-K, 2912528.
10. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 2004, 4(12):941-952. 10.1038/nri1498, 15573129.
11. Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA, Banchereau J. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999, 190(10):1417-1426. 10.1084/jem.190.10.1417, 2195690, 10562317.
12. Tsuge T, Yamakawa M, Tsukamoto M. Infiltrating dendritic/Langerhans cells in primary breast cancer. Breast Cancer Res Treat 2000, 59(2):141-152. 10.1023/A:1006396216933, 10817349.
13. Sombroek CC, Stam AG, Masterson AJ, Lougheed SM, Schakel MJ, Meijer CJ, Pinedo HM, van den Eertwegh AJ, Scheper RJ, de Gruijl TD. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 2002, 168(9):4333-4343.
14. Della Bella S, Gennaro M, Vaccari M, Ferraris C, Nicola S, Riva A, Clerici M, Greco M, Villa ML. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer 2003, 89(8):1463-1472. 10.1038/sj.bjc.6601243, 2394334, 14562018.
15. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2005, 2(9):e284. 10.1371/journal.pmed.0020284, 1198041, 16124834.
16. Delemarre FG, Hoogeveen PG, De Haan-Meulman M, Simons PJ, Drexhage HA. Homotypic cluster formation of dendritic cells, a close correlate of their state of maturation. Defects in the biobreeding diabetes-prone rat. J Leukoc Biol 2001, 69(3):373-380.
17. Zuidwijk K, de Fijter JW, Mallat MJ, Eikmans M, van Groningen MC, Goemaere NN, Bajema IM, van Kooten C. Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome. Kidney Int 2011, 81(1):64-75.
18. Leithauser F, Meinhardt-Krajina T, Fink K, Wotschke B, Moller P, Reimann J. Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am J Pathol 2006, 168(6):1898-1909. 10.2353/ajpath.2006.050228, 1606612, 16723705.
19. Holmes S, Kapelner A, Lee PP. An interactive java statistical image segmentation system: GemIdent. J Stat Softw 2009, 30(10):pii: i10.
20. Setiadi AF, Ray NC, Kohrt HE, Kapelner A, Carcamo-Cavazos V, Levic EB, Yadegarynia S, van der Loos CM, Schwartz EJ, Holmes S, et al. Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes. PLoS One 2010, 5(8):e12420. 10.1371/journal.pone.0012420, 2928294, 20811638.
21. Chen DZ, Smid M, Xu B. Geometric algorithms for density-based data clustering. Int J Comput Geometry Appl 2005, 15(3):239-260.
22. Miller MJ, Safrina O, Parker I, Cahalan MD. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med 2004, 200(7):847-856. 10.1084/jem.20041236, 2213293, 15466619.
23. Pinzon-Charry A, Maxwell T, Lopez JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 2005, 83(5):451-461. 10.1111/j.1440-1711.2005.01371.x, 16174093.
24. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005, 5(4):296-306. 10.1038/nri1592, 15803149.
25. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010, 363(5):411-422. 10.1056/NEJMoa1001294, 20818862.
26. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313(5795):1960-1964. 10.1126/science.1129139, 17008531.
27. Isse K, Lesniak A, Grama K, Roysam B, Minervini MI, Demetris AJ. Digital transplantation pathology: combining whole slide imaging, multiplex staining and automated image analysis. Am J Transplant 2012, 12(1):27-37. 10.1111/j.1600-6143.2011.03797.x, 22553852.
28. Fiore C, Bailey D, Conlon N, Wu X, Martin N, Fiorentino M, Finn S, Fall K, Andersson SO, Andren O, et al. Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry. J Clin Pathol 2012, 65(6):496-502. 10.1136/jclinpath-2012-200734, 3437674, 22447914.
29. Fujimoto Y, Tedder TF. CD83: a regulatory molecule of the immune system with great potential for therapeutic application. J Med Dent Sci 2006, 53(2):85-91.
30. Hillenbrand EE, Neville AM, Coventry BJ. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours. Br J Cancer 1999, 79(5-6):940-944. 2362664, 10070894.
31. Coventry BJ, Lee PL, Gibbs D, Hart DN. Dendritic cell density and activation status in human breast cancer - CD1a, CMRF-44, CMRF-56 and CD-83 expression. Br J Cancer 2002, 86(4):546-551. 10.1038/sj.bjc.6600132, 2375292, 11870535.
32. Mansfield AS, Heikkila P, von Smitten K, Vakkila J, Leidenius M. Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8+ T cells. Virchows Arch 2011, 459(4):391-398. 10.1007/s00428-011-1145-3, 21894561.
33. Coventry B, Heinzel S. CD1a in human cancers: a new role for an old molecule. Trends Immunol 2004, 25(5):242-248. 10.1016/j.it.2004.03.002, 15099564.
34. Lokshin AE, Kalinski P, Sassi RR, Mailliard RB, Muller-Berghaus J, Storkus WJ, Peng X, Marrangoni AM, Edwards RP, Gorelik E. Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II. Int Immunol 2002, 14(9):1027-1037. 10.1093/intimm/dxf073, 12202400.
35. Corinti S, Fanales-Belasio E, Albanesi C, Cavani A, Angelisova P, Girolomoni G. Cross-linking of membrane CD43 mediates dendritic cell maturation. J Immunol 1999, 162(11):6331-6336.